As the demand for tailored lipids grows, the complexity of their development and synthesis has increased significantly. This session will provide insights into the challenges of creating high-quality custom lipids essential for lipid nanoparticles (LNPs) in clinical applications.
We will focus on the expertise needed for successful lipid development and the importance of early planning to enable smooth scale-up to GMP standards. Participants will learn how lipid quality influences the performance and safety of LNPs, vital e.g. for mRNA vaccines and gene therapies. Additionally, participants will gain insights into how navigating the regulatory landscape effectively can streamline the path to clinical trials and market entry, ensuring that innovative therapies meet the necessary requirements.
In this webinar, you will learn:
- the complexities of developing high quality custom lipids and the critical parameters required for successful scale-up to GMP manufacturing
- the regulatory landscape and requirements for lipid development and drug products, focusing on pathways to successful clinical phases and commercial manufacturing
Speakers

Christian Kuzniewski, Ph.D.
Merck
Project Manager - Lipid Process Development
Christian earned a Ph.D. in chemistry from ETH Zürich and serves as a project manager for the lipids process development team in Schaffhausen, Switzerland. Together with his team, he focuses on developing and optimizing lipid syntheses for transfer to GMP production, facilitating clinical and commercial applications in LNP-based therapeutics. His team has been instrumental in the development and scale-up of several commercial lipids, including those utilized in COVID-type vaccines.

Lotfi Bouchekioua
Merck
Regulatory Affairs Expert
Lotfi is a regulatory affairs expert within our global regulatory affairs organization, specializing in CMC regulatory strategy and compliance. He develops and implements global CMC regulatory strategies for priority assets, leading submissions and lifecycle management activities multiple markets. He serves as a key liaison with global Health Authorities, managing CMC-related queries to accelerate approvals and ensure regulatory alignment. He joined Merck in 2023 after holding various roles in regulatory affairs. He is a pharmacist with a master's degree in health law.
Pharma and biopharma manufacturing
- Pharma and biopharma manufacturing
期间:1h
语言:English
场次 1:Thu, December 4, 2025 4:00 PM CEST
如要继续阅读,请登录或创建帐户。
暂无帐户?